Retinoblastoma Bilateral

2

Review clinical trials related to Retinoblastoma Bilateral. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Retinoblastoma Patient Clinical Database and Tissue Repository

Retinoblastoma (RB) is a primary eye cancer that forms in the back of the eye of infants and toddlers. Traditionally, RB is diagnosed without a biopsy; tumor can only be studied once an eye has been surgically removed. Given this limitation, we use aqueous humor (AH), the clear fluid in the front of the eye to detect specific markers, or information, that comes from the tumor itself.

Participants needed: 800
Trial details
Age: 0-18Biological sex: AllType: ObservationalSponsor: Children's Hospital Los AngelesUpdated: Apr 22, 2026Locations: 9Duration: 3 Years
Eligibility criteria

All patients, age 0 days to 18 years, with a diagnosis unilateral or bilateral r...

Patients referred for second opinions only and not treated at CHLA for any reaso...

Status: Recruiting

Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis.

The goal of this observational study is undertake a detailed phenotypic and genotypic study of patients with ocular and secondary cancers due to mutations in the RB1 gene. Our research sequencing approach will allow advanced insight to for further detailed genotypic understanding of parent-of-origin for valuable insight into the genotype-phenotype relationship of this cancer syndrome.

Participants needed: 100
Trial details
Biological sex: AllType: ObservationalSponsor: University of WashingtonUpdated: Mar 18, 2026Locations: 1
Eligibility criteria

Patients with molecularly proven retinoblastoma due to RB1 or a typical clinical... [+1]

Patients unable or unwilling to undertake consent or clinical testing. [+1]